Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

Recent advancements suggest that a significant competitor to Keytruda, the world’s top-selling cancer therapy, might be emerging.,Keytruda, manufactured b... "Lorem ipsum dolor sit amet, consectetur ...

Headlines,Summit Therapeutics surged 123% this week due to promising phase 3 trial results for its lung cancer antibody, ...

Moderna plans to cut $1.1bn in costs by 2027, pausing and scrapping several R&D programs. See why I think further downside ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of GSE Systems, Inc. (NASDAQ: GVP) to Pelican Energy Partners for $4.10 per share in cash is fair to GSE shareholders.

Merck’s Keytruda Combo for Urothelial Carcinoma Gets EU Approval: The European Commission granted approval to Merck’s Keytruda in combination with Astellas/Pfizer’s antibody-drug conjugate ...

DoubleVerify (“DV”) (NYSE: DV), a leading software platform for digital media measurement, data and analytics, today announced the rollout of DV’s Inflammatory ...

More details about the projects and organizations receiving funding can be found in the backgrounder below. Quotes "Vancouver Island has an amazing combination of talent, resources and ambition. Local ...

Merck's Keytruda therapy received approval from the European Union, in combination with antibody-drug Padcev, as a first-line cancer treatment. The pharmaceutical company said Tuesday that the ...

And there are some excellent Labor Day quotes from influential activists and inspiring individuals to help us all celebrate. Related: Should You Expect USPS Mail Delivery on Labor Day? When Is ...